Retatrutide is an investigational peptide studied for weight loss, glucose regulation, and metabolic health
Patients should maintain open communication with their healthcare providers about body composition changes during semaglutide treatment
WeightWatchers also is moving into the obesity drug market with its recent acquisition of telehealth company Sequence for $132 million
These dairy products are high in protein and low in carbohydrates, making them excellent snack options
To date, GLP-1 RAs have demonstrated efficacy in obese patients with HFpEF, but data in HFrEF remain scarce
Same Price at Every Dose: What Eden's Published Terms Actually Say Eden's published materials describe a "Same Price at Every Dose" policy for standard full-price purchases, meaning consistent pricing regardless of dosage adjustments throughout the program